Showing 581-590 of 5688 results for "".
A Special Farewell
https://modernod.com/editorial-series/significant-findings/a-special-farewell/51491/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all cuThe OmniVu™ Lens System
https://modernod.com/articles/visionary-breakthroughs/the-omnivusupsup-lens-system/39820/Atia Vision designs a “no-compromise” PC-IOL.How to Tackle RCEs With Ease
https://modernod.com/articles/significant-findings/how-to-tackle-rces-with-ease/37854/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatHearing and the Retina: A (Not-So) Surprising Link
https://modernod.com/articles/significant-findings/hearing-and-the-retina-a-not-so-surprising-link/37853/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatReady to Embrace the Newest Dry Eye Drop?
https://modernod.com/articles/significant-findings/ready-to-embrace-the-newest-dry-eye-drop/37850/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatSurvey Says …
https://modernod.com/articles/significant-findings/survey-says/37794/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatThe Rundown on Vevye
https://modernod.com/videos/eye-care-insiders/the-rundown-on-vevye/37342/Joseph J. Allen, OD, FAAO, Dipl ABO, goes over what you need to know about the recently FDA-approved, nonpreserved cyclosporine ophthalmic solution 0.1% (Vevye, Novaliq) for treating the signs and symptoms of dry eye disease. He discusses what makes the drop unique compared with other cyclosporine pVitamin A and OSD: the Good, the Bad, and the Ugly
https://modernod.com/topics/ocular-surface/vitamin-a-and-osd-the-good-the-bad-and-the-ugly/38769/Understand the therapeutic benefits and potential adverse effects associated with products containing vitamin A derivatives.Treating Ocular Surface Disease With Scleral Lenses
https://modernod.com/topics/contact-lenses/treating-ocular-surface-disease-withscleral-lenses/37927/These lenses can benefit patients with dry eye and other ocular surface diseases for whom alternative treatment options have been ineffective.Crazy New Info About Presbyopia Drops
https://modernod.com/articles/significant-findings/crazy-new-info-about-presbyopia-drops/39849/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat